11–14 March Abarceo attended the ATTD in Barcelona. Abarceo promoted its development to become the first company to provide the diabetes community with a drug that will adress major hallmarks of diabetes. That is including restoration of patients own insulin...
On World Diabetes Day, we at Abarceo Pharma AB stand with the millions of people around the world living with type 1 diabetes – a chronic autoimmune disease with no apparent treatment. Abarceo pledges to bring a new, disease modifying, treatment to type -1 and type -2...
World Diabetes Day on November 14 raised awareness of diabetes as one of the greatest public health challenges of our time, along with the importance of ensuring access to adequate care for everyone affected. Claes Wollheim, founder of Abarceo Pharma, has dedicated...
Today ABARCEO PHARMA is celebrating the birthday of Sir Frederick Banting, who discovered insulin. It is also the World Diabetes Day, this year with the theme, “Breaking Barries, Bridging Gaps”Truly the spirit that we at Abarceo live and work by in the...
Abarceo Pharma får Almi Invest som ny delägare när de nu tar in total 21,5 miljoner kroner. Pengarna ska räcka i ett år och bland annat användas för att bestämma vilken läkemedelskandidat som de ska utveckla vidare. Bolaget har i nuläget flera möjliga kandidater för...
Recent Comments